ASBPW

Aspire Biopharma Holdings, Inc. Warrant

33 hedge funds and large institutions have $4.48M invested in Aspire Biopharma Holdings, Inc. Warrant in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
-1
Holders Change %
-2.94%
% of All Funds
0.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
2
Closed
2
Calls
$724K
Puts
Net Calls
+$724K
Net Calls Change
+$10K
Name Holding Trade Value Shares
Change
Shares
Change %
Barclays
1
Barclays
United Kingdom
$3.95M
AC
2
Athos Capital
Hong Kong
$241K
HCM
3
Highbridge Capital Management
New York
$45K -$25.5K
SCM
4
Saba Capital Management
New York
$36.8K
LA
5
Linden Advisors
New York
$32.6K
PC
6
Periscope Capital
Ontario, Canada
$30.6K -$24.1K -643,365 -44%
AA
7
AQR Arbitrage
Connecticut
$19.5K
SC
8
Sculptor Capital
New York
$18.7K
WAM
9
Wolverine Asset Management
Illinois
$18K
Verition Fund Management
10
Verition Fund Management
Connecticut
$13K
TCA
11
Taconic Capital Advisors
New York
$9.03K
PAMP
12
Polar Asset Management Partners
Ontario, Canada
$6.22K
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$6.02K
WA
14
Whitebox Advisors
Minnesota
$5.61K
LP
15
LMR Partners
United Kingdom
$5.61K
FSI
16
Flow State Investments
Illinois
$5.1K
CSD
17
Clear Street Derivatives
New York
$4.76K
Nomura Holdings
18
Nomura Holdings
Japan
$4.5K
KL
19
KIM LLC
Kansas
$4.49K
EAM
20
Exos Asset Management
New York
$4.11K
CCM
21
CAAS Capital Management
New York
$3.37K
JPMorgan Chase & Co
22
JPMorgan Chase & Co
New York
$3.01K -$3.01K
CS
23
Clear Street
New York
$2.38K -$4 -100 -0.2%
Walleye Capital
24
Walleye Capital
New York
$2.09K
ACM
25
Atalaya Capital Management
New York
$1.5K